[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619979":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":36,"centralContacts":40,"locations":46,"responsibleParty":63,"collaborators":11,"id":66,"slug":11,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":11,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":11,"enrollmentInfo":74,"targetDuration":11,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":11,"overallStatus":49,"whyStopped":11,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8,16,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Community dwelling adults","EXPERIMENTAL",null,[13,14,15],"Diagnostic Test: Focused Cardiac Ultrasound","Diagnostic Test: 6-Lead AI-ECG","Diagnostic Test: 12-Lead AI-ECG",{"label":17,"type":10,"description":11,"interventionNames":18},"Pregnant women",[13,14,15],{"label":20,"type":10,"description":11,"interventionNames":21},"Adolescents and young adults",[13,14,15],[23,28,32],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":11},"DIAGNOSTIC_TEST","Focused Cardiac Ultrasound","Focused cardiac ultrasound will utilize sonography to evaluate specific cardiac conditions, such as ventricular function, pericardial effusion, and valvular abnormalities.",[20,9,17],{"type":24,"name":29,"description":30,"armGroupLabels":31,"otherNames":11},"6-Lead AI-ECG","A 6-lead ECG uses six electrodes placed on the chest and limbs to record the heart's electrical activity from multiple perspectives.",[20,9,17],{"type":24,"name":33,"description":34,"armGroupLabels":35,"otherNames":11},"12-Lead AI-ECG","A standard 12-lead ECG consists of 12 leads: 6 limb leads and 6 chest (precordial) leads. These leads record the heart's electrical activity from different angles to provide a comprehensive assessment of cardiac function.",[20,9,17],[37],{"name":38,"affiliation":5,"role":39},"Paul Friedman, MD","PRINCIPAL_INVESTIGATOR",[41],{"name":42,"role":43,"phone":44,"phoneExt":11,"email":45},"Amanda Priebe","CONTACT","507-422-6932","Priebe.Amanda@mayo.edu",[47],{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Mayo Clinic in Rochester","RECRUITING","Rochester","Minnesota","55905","United States",{"type":55,"coordinates":56},"Point",[57,58],-92.4699,44.02163,{"lat":58,"lon":57},[61,62],{"name":42,"role":43,"phone":44,"phoneExt":11,"email":45},{"name":38,"role":39,"phone":11,"phoneExt":11,"email":11},{"type":39,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Paul A. Friedman","Principal Investigator","100619979",false,"NCT07351656","A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound","Screening for Heart Disease Using AI-Enabled Electrocardiography and Focused Cardiac Ultrasound: the AI CVD Screen Study.","Adolescents and young adults:\n\nInclusion Criteria:\n\n* Enrollment in a high-school, college or a resident in MN during the study period\n* Age 15-29 years\n* Informed consent (and assent for minors)\n\nExclusion Criteria:\n\n* Presence of a pacemaker or defibrillator\n* Inability to obtain a quality ECG tracing\n\nCommunity dwelling adults:\n\nInclusion Criteria:\n\n• Adult patients (\\>30 years of age, with pre-specified subgroups 30-64 and 65+))\n\nExclusion Criteria:\n\n• Inability to provide informed consent to participate in the study\n\nPregnant women:\n\nInclusion Criteria:\n\n* Adult female aged 18 to 49 years\n* Pregnant at the time of enrollment\n* Receiving obstetric care at identified study site(s)\n* Willing and able to provide informed consent\n\nExclusion Criteria:\n\n• Inability to provide consent","ALL","15 Years",{"count":75,"type":76},19300,"ESTIMATED","INTERVENTIONAL",[79],"NA","A study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.",[82],"Heart Disease","2026-05-12",{"date":85,"type":86},"2026-05-14","ACTUAL",{"date":88,"type":86},"2026-03-09",{"date":90,"type":76},"2028-02",{"name":5,"class":6},1]